Found 5 matching trials
Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease PHASE1 This is a Phase I, double-blind, placebo-controlled study to evaluate the s...
Show More Location
CMAX Clinical Research Pty Ltd
Learn More & Join Trial
A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole PHASE1 A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214-...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
A Study to Compare PK, PD and Safety of the AD-214 and AD-2141 PHASE1 A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 ...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers PHASE1 This is a first in human (FIH), multi-center, dose escalating study to eval...
Show More Location
Scientia Clinical Research Ltd
Learn More & Join Trial
A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole PHASE1 A study to compare safety, pharmacokinetics and pharmacodynamics of AD-214 ...
Show More Location
Seoul National University Hospital
Learn More & Join Trial